Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guidant (GDT) -- Ignore unavailable to you. Want to Upgrade?

To: Lighthouse who wrote (178)	7/11/2001 9:58:55 PM
From: D.Austin	Read Replies (1) \| Respond to of 235

Good call Lighthouse-yesterdays news mixed with todays fall makes my mouth water.Does this statement below mean that Guidant will not get their's approved.......NO No nO...... This is a great company going through tough times,,,,,,,,, but great times to add to your shares.(or in your case get back in )I too sold the majority of my shares but I always keep my free shares. I have a strange fetish of collecting Earnings Reports too,so I cannot totally unload. cheers,to you also----I also see that GDT is up 2.50 AH fortune.com./indexw.jhtml?channel=thirdparty.jhtml&xpage=http://sites.stockpoint.com/fortune2/newspaper.asp?Mode=%26Story=20010711%5C192e6870%2Exml Separately, medical device maker Guidant dropped $5.10, or 14 percent, to$31.31, after the FDA rejected a pacemaker developed by the company. After theclose of New York trading, news broke that the FDA had approved a competingpacemaker made by Medtronic.